Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-13,567
Closed -$342K 1465
2015
Q1
$342K Buy
13,567
+237
+2% +$5.97K ﹤0.01% 995
2014
Q4
$313K Sell
13,330
-448
-3% -$10.5K ﹤0.01% 1090
2014
Q3
$314K Buy
+13,778
New +$314K 0.01% 858
2014
Q1
Sell
-4,925
Closed -$117K 1398
2013
Q4
$117K Hold
4,925
﹤0.01% 1110
2013
Q3
$105K Sell
4,925
-363
-7% -$7.74K ﹤0.01% 1083
2013
Q2
$105K Buy
+5,288
New +$105K ﹤0.01% 1110

Other funds holding QGENF

KBC Group's QGENF Position: Q2 2015 in Review

KBC Group sold out of QIAGEN NV (QGENF) in Q2 2015, closing a stake of 13,567 shares — an estimated $342K sold.

KBC Group first reported a position in QGENF in Q2 2013 and held it in 6 quarters. The position peaked at $342K in Q1 2015. 179 funds tracked by Wall St. Rank hold QGENF as of Q2 2015.

  • KBC Group reported no remaining QIAGEN NV position as of Q2 2015 after selling out during the quarter.
  • KBC Group sold 13,567 QIAGEN NV shares in Q2 2015, an estimated $342K.
  • KBC Group first reported a position in QIAGEN NV in Q2 2013 and held it in 6 quarters.
  • KBC Group's QIAGEN NV position peaked at $342K in Q1 2015.
  • 179 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2015.

Based on KBC Group's 13F filing for Q2 2015, filed 31 Jul 2015.